Sort
16,300 grants matching “fatty liver disease”
A lipid-induced RNA-binding protein in atherosclerosis
$466,897Paul C. Dimayuga · Cedars-Sinai Medical Center · R01 · FY2022 · HL
NR4A Orphan Receptors And Insulin Resistance
$466,847W Timothy Garvey · University Of Alabama At Birmingham · R01 · FY2011 · DK
NR4A Orphan Receptors And Insulin Resistance
$466,847W Timothy Garvey · University Of Alabama At Birmingham · R01 · FY2012 · DK
Establishment and Maintenance of Healthy Adipose Tissue in Obesity
$466,806Rana K. Gupta · Ut Southwestern Medical Center · R01 · FY2021 · DK
Project 2: Regulation of lipid and glucose metabolism by ANGPTL3 in humans
$466,793Nathan Oliver Stitziel · University Of Washington · P01 · FY2024 · HL
Mechanisms of NAT2 Regulation of Insulin Resistance and Mitochondrial Dysfunction
$466,648Joshua Wiley Knowles · Stanford University · R01 · FY2019 · DK
Impact of Epidemiologically Based Phthalate Exposures on Female Reproduction and Metabolism
$466,470Zelieann Rivera Craig · University Of Arizona · R01 · FY2025 · ES
Vinyl chloride modifies the risk for nonalcoholic fatty liver disease
$466,452Juliane I Beier · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · DK
Vinyl chloride modifies the risk for nonalcoholic fatty liver disease
$466,452Juliane I Beier · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · DK
Vinyl chloride modifies the risk for nonalcoholic fatty liver disease
$466,452Juliane I Beier · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · DK
Ectopic adiposity in black men with high type 2 diabetes risk
$466,412Iva Miljkovic · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · DK
Interactions between prenatal obesogen exposure and Total Western diet lead to a transgenerational thrifty phenotype: functional and epigenomic analysis of effects in fat and liver
$466,372Bruce Blumberg · University Of California-Irvine · R01 · FY2022 · ES
Characterizing zonated hepatocyte sexual dimorphism and its role in fatty liver disease
$466,320Bruce Mao Zheng Wang · University Of California, San Francisco · R01 · FY2024 · DK
Aerobic Fitness, Mitochondrial Function, and Fatty Liver Disease.
$466,270John P Thyfault · University Of Kansas Medical Center · R01 · FY2020 · DK
Accurate Measurement of Renal Function in Cirrhosis
$466,222Vivian S Lee · University Of Utah · R01 · FY2011 · DK
Nonalcoholic Steatohepatitis: Natural History and Therapy
$466,145T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · Z01 · FY2008 · DK
Aerobic Fitness, Mitochondrial Function, and Fatty Liver Disease.
$465,985John P Thyfault · University Of Kansas Medical Center · R01 · FY2021 · DK
Neurocognitive and Metabolic Effects of Mild Hypothyroidism
$465,944Mary H. Samuels · Oregon Health & Science University · R01 · FY2009 · DK
The Saint Louis University Component of the NASH Clinical Research Network
$465,925Brent A Neuschwander-Tetri · Saint Louis University · U01 · FY2016 · DK
Targeting a Ceramide Double Bond to Treat Cardiometabolic Disorders
$465,796Scott A Summers · University Of Utah · R01 · FY2020 · DK
Targeting a Ceramide Double Bond to Treat Cardiometabolic Disorders
$465,796Scott A Summers · University Of Utah · R01 · FY2022 · DK
Targeting a Ceramide Double Bond to Treat Cardiometabolic Disorders
$465,796Scott A Summers · University Of Utah · R01 · FY2021 · DK
Glyoxalase 1 and its Role in Metabolic Syndrome
$465,631James J Galligan · University Of Arizona · R01 · FY2025 · DK
Characterization of the role of neuropeptide VIP-mediated fucosylation in alcohol associated liver disease
$465,588Zhong-Bin Deng · University Of Louisville · R01 · FY2023 · AA
Lipid Aldehyde and Ethanol Induced Liver Damage
$465,533Dennis Petersen · University Of Colorado Denver · R37 · FY2015 · AA